By Fineline Cube 
China’s National Health Commission (NHC) has released the 2025 Key Tasks for Rectifying Improper Practices in Pharmaceutical Procurement and Medical Services, signaling a commitment to deepen governance reforms across healthcare supply chains and service delivery.
Enhanced Monitoring and Supervision
The document mandates the establishment of enhanced monitoring and early warning systems to address emerging, evolving, and concealed issues within the healthcare sector. It emphasizes close supervision of ‘critical few’ personnel and key positions, with prioritized oversight on pharmaceuticals, high – value consumables, medical equipment, infrastructure/IT bidding, and logistical services.
Standardization and Enforcement
Critical processes including off – site specimen testing, external prescriptions, project approvals, and fund allocation will undergo continuous standardization. The NHC will intensify administrative law enforcement and judicial actions, leveraging tools such as prescription audits, AI alerts, surprise inspections, performance assessments, hospital audits, abnormal billing reviews, statistical/audit analyses, and complaint resolution.
Focus Areas and Anti-Corruption Measures
The campaign will focus on addressing patient privacy violations, genetic testing malpractices, assisted reproduction, cosmetic medicine, childhood myopia prevention, and fraudulent medical certifications. In – depth anti – corruption campaigns in funeral services will also be conducted, with zero – tolerance anti – graft measures maintained to ensure integrity throughout the healthcare system.-Fineline Info & Tech